Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSIP1 | O75475 | 2/20 | 1.00 |
| ▸ | HSD11B1 | P28845 | 5/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | HTR6 | P50406 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA3 | P07451 | 1/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | CA6 | P23280 | 1/20 | 0.48 |
| ▸ | CA5A | P35218 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL6978426 | 0.97 | PSIP1 (0.95) | PSIP1HSD11B1GAAHTR6POLB | |
| Fluoride SCHEMBL9493182 | 0.97 | PSIP1 (0.95) | PSIP1HSD11B1GAAHTR6POLB | |
| Methylamine SCHEMBL28266275 | 0.95 | PSIP1 (0.90) | PSIP1HSD11B1GAAHTR6POLB | |
| Sulfuric Acid SCHEMBL27681094 | 0.93 | PSIP1 (0.86) | PSIP1HSD11B1GAAHTR6POLB | |
| SCHEMBL27891797 | 0.93 | PSIP1 (0.86) | PSIP1HSD11B1GAAHTR6POLB | |
| SCHEMBL789569 | 0.91 | PSIP1 (0.82) | PSIP1HSD11B1GAAHTR6POLB | |
| Methylphenylsulfone SCHEMBL9733545 | 0.91 | PSIP1 (0.82) | PSIP1HSD11B1GAAPOLBALDH1A1 | |
| SCHEMBL14431973 | 0.91 | PSIP1 (0.82) | PSIP1HSD11B1GAAHTR6POLB | |
| Acetic Acid SCHEMBL28112958 | 0.91 | PSIP1 (0.82) | PSIP1HSD11B1GAAPOLBALDH1A1 | |
| Phenol SCHEMBL28291911 | 0.89 | PSIP1 (0.78) | PSIP1HSD11B1GAAPOLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1047 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026103414-A1 | METHOD FOR OBSERVING MICROSCOPIC FORMATION PROCESS OF POROUS MEMBRANE PREPARED BY PHASE SEPARATION METHOD | 中国科学院大连化学物理研究所 | 2026-05-21 | — | — | WO | claimed |
| US-12537221-B2 | Electrolyte for secondary battery and secondary battery including the same | DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2026-01-27 | — | — | US | claimed |
| US-20250391919-A1 | ELECTROLYTE SOLUTION, BATTERY CELL, BATTERY, AND POWER CONSUMING APPARATUS | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2025-12-25 | — | — | US | claimed |
| EP-4664591-A1 | ELECTROLYTE SOLUTION, BATTERY CELL, BATTERY, AND ELECTRIC DEVICE | Contemporary Amperex Technology Co., Limited (CN) | 2025-12-17 | — | — | EP | claimed |
| CN-120019522-A | Electrolyte, battery cell, battery and electricity utilization device | 宁德时代新能源科技股份有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-119789746-A | Solar cell and preparation method thereof | 北京曜能光电科技有限公司 | 2025-04-08 | — | — | CN | claimed |
| CN-119452496-A | Electrolyte, battery and electricity utilization device | 宁德时代新能源科技股份有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-119361837-A | Anion-regulated weak solvation sulfonyl electrolyte and preparation method thereof | 临沂大学 | 2025-01-24 | — | — | CN | claimed |
| WO-2024182918-A1 | ELECTROLYTE, BATTERY AND ELECTRICAL APPARATUS | 宁德时代新能源科技股份有限公司 | 2024-09-12 | — | — | WO | claimed |
| CN-117154224-B | Deep eutectic electrolyte additive capable of solubilizing lithium salt, electrolyte and lithium battery | 常州千沐新能源有限公司 | 2024-07-12 | — | — | CN | claimed |
| EP-0602914-B1 | Ink compositions for ink jet printing | XEROX CORP (US) | 1997-11-12 | — | — | EP | claimed |
| WO-1996041626-A1 | COMPOSITIONS COMPRISING A CYCLOOXYGENASE-2 INHIBITOR AND A 5-LIPOXYGENASE INHIBITOR | G.D. SEARLE & CO. (US) | 1996-12-27 | — | — | WO | claimed |
| EP-0724566-A1 | 1,2-DIARYLCYCLOPENTENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-08-07 | — | — | EP | claimed |
| US-5512561-A | ANALGESICS, PROSTAGLANDIN ANTAGONIST | G. D. SEARLE & CO. (US) | 1996-04-30 | — | — | US | claimed |
| WO-1995011883-A1 | 1,2-DIARYLCYCLOPENTENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1995-05-04 | — | — | WO | claimed |
| US-5393878-A | Pyrimidine nucleosides having cyclopentafuran skeleton | CIBA-GEIGY CORPORATION (US) | 1995-02-28 | — | — | US | claimed |
| US-5319080-A | Antiviral agents | CIBA-GEIGY CORPORATION (US) | 1994-06-07 | — | — | US | claimed |
| US-5300143-A | Water soluble dye, sulfone, and amide or cyclic amine | XEROX CORPORATION (US) | 1994-04-05 | — | — | US | claimed |
| EP-0352575-A2 | Substituted annealed pyrroles | BAYER AG (DE) | 1990-01-31 | — | — | EP | claimed |
| EP-0317845-A2 | Substituted hydroxyl amines | BAYER AG (DE) | 1989-05-31 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12537221-B2 | Electrolyte for secondary battery and secondary battery including the same | NCS1, KCNN2, SLC9A1 | PSIP1 2318/4885HSD11B1 1060/4885GAA 4063/4885 |
| US-20250391919-A1 | ELECTROLYTE SOLUTION, BATTERY CELL, BATTERY, AND POWER CONSUMING APPARATUS | HCN1, NHERF1, HCN2 | PSIP1 2006/4885HSD11B1 138/4885GAA 3993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.